A Good Cancer research Bio company? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : A Good Cancer research Bio company?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: B. Ino who wrote (10)	9/5/1996 5:42:00 PM
From: Rick Costantino	of 76

I highly recommend IDEC pharmaceuticals (IDPH:NASDAQ). They are in phase III of their lead drug IDEC-C2B8, primitized IgG anti-CD-18, for treatment of non-hodgkins lymphoma. The drug shows outstanding efficacy so far (an interim report was made public several months ago). They are trying to get approval by end of 96, but 97 is more likely. IMO, this is about as close to a "sure thing" as you can get in the biotech area. Check out the thread here. If interested, I would keep an eye on this one and get in around $16-18 on a dip. If you make any decision on which stocks to buy, please pot here; we are interested! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next